Articles From: Signature Group Holdings, Inc. Reports Second Quarter 2014 Results to Regulus to Present at the Wedbush Life Sciences Management Access Conference


-Operating Costs Drop 19.8%- -Industrial Supply Net Sales Increase 7.4%- -Cash Position Increases while Debt Decreases $2.1 Million- SHERMAN OAKS, Calif.
Sign-up for Signature Group Holdings, Inc. Reports Second Quarter 2014 Results investment picks
MILL VALLEY, Calif.
Sign-up for Redwood Trust Declares $0.28 Per Share Dividend For The Third Quarter Of 2014 investment picks
Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED ® technology and materials, today reported financial results for the second quarter ended June 30, 2014.
Sign-up for Universal Display Corporation Announces Second Quarter 2014 Financial Results investment picks
MONROE, La.
Sign-up for CenturyLink to Participate in Analyst Conferences investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961646001&sourceType=1 http://www.ccnmatthews.com/logos2/senvest.jpg MONTREAL, QUEBEC --
Sign-up for Senvest Capital Inc. Reports Results for the Second Quarter Ended June 30, 2014 investment picks
Kemper Corporation (NYSE: KMPR) reported today net income of $9.3 million, or $0.17 per diluted share, for the second quarter of 2014, compared to $34.0 million, or $0.59 per diluted share, for the second quarter of 2013.
Sign-up for Kemper Corporation Reports Second Quarter 2014 Earnings investment picks
Adjusted EBITDA Increases 27% to $77.3 Million Adjusted Basic Net Income per Share Doubles to $0.36 $159.8 Million in Free Cash Flow Delivered in the Quarter SANTA MONICA, Calif.
Sign-up for LIONSGATE REPORTS RESULTS FOR FIRST QUARTER 2015 investment picks
Strong RevPAR Increase of 7.7% for All Hotels for the Second Quarter DALLAS , Aug.
Sign-up for Ashford Trust Reports Second Quarter 2014 Results investment picks
MILL VALLEY, Calif.
Sign-up for Redwood Trust Reports Second Quarter 2014 Results investment picks
ALISO VIEJO, Calif.
Sign-up for Sunstone Hotel Investors Reports Results For Second Quarter 2014 investment picks
BRAINTREE, Mass., Aug.
Sign-up for Altra Industrial Motion Corp. to Present at Jefferies 2014 Global Industrials Conference investment picks
Total revenue of $32.3 million grew 33% year-over-year CHARLESTON, S.C., Aug.
Sign-up for Benefitfocus Announces Second Quarter 2014 Financial Results investment picks
BERKELEY, Calif.
Sign-up for Annie's Reports First Quarter Financial Results, Reaffirms Full Year Guidance investment picks
VANCOUVER , Aug.
Sign-up for International Tower Hill Mines Files 2014 Second Quarter Financial Results investment picks
Net Income (Loss) - $(0.3) million Adjusted; $12.1 million GAAP Revenue - $122.8 million Adjusted (Education down 19%, Enterprise up 45% year-over-year); $137.5 million GAAP Adjusted EBITDA - $10.3 million Unveiled new SMART kapp™ capture board Launched SMART amp™ and Notebook Advantage education software Launched SMART Board 6065 education interactive flat panel CALGARY, Alberta, Aug.
Sign-up for SMART Reports First Quarter 2015 Financial Results investment picks
Recent Highlights BURLINGTON, Mass., Aug.
Sign-up for Flexion Therapeutics Reports Second-Quarter 2014 Financial Results investment picks
Engility Holdings, Inc. (NYSE: EGL) today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Engility Reports Second Quarter 2014 Results investment picks
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing PRX302 for the treatment of the symptoms of benign prostatic hyperplasia (BPH, enlarged prostate) and for the treatment of localized prostate cancer, today announced financial results and recent key operational and financial highlights for the three and six months ended June 30, 2014.
Sign-up for Sophiris Bio Reports Second Quarter Financial Results and Key Operational and Financial Highlights investment picks
DALLAS, Aug.
Sign-up for Speed Commerce Reports Fiscal First Quarter 2015 Results investment picks
2014/8/7
UCD Product Portfolio Generates $37.1 Million in Net Sales During the Quarter --$31.6 million of RAVICTI® recognized in the quarter including $11.7 million of previously deferred revenue --Adjusted net income of $21.1 million earned in quarter Company to Host Conference Call Today at 4:30 p.m. ET (1:30 p.m. PT) BRISBANE, Calif., Aug.
Sign-up for Hyperion Therapeutics Announces Second Quarter 2014 Financial Results investment picks
Ireland Inc. ( OTCBB: IRLD ) today announced that the Company will host an investor update conference call on Thursday, August 14, 2014 at 1:30 p.m. PDT (4:30 p.m. EDT). The purpose of this call is to update investors regarding the progress and developments related to the gold and silver extraction process at the Columbus Project and its on-site pilot plant located in Nevada.
Sign-up for Ireland Inc. to Host Q2 Results Conference Call on Thursday, August 14, 2014 investment picks
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, reported financial results for the second quarter ended June 30, 2014, and also provided an overview of certain corporate accomplishments and plans.
Sign-up for Verastem Reports Second Quarter 2014 Financial and Corporate Results investment picks
Net loss of $70,000, reduced $1.6 million from same period last year Oculus owns two million shares of Ruthigen (Nasdaq:RTGN) Net worth of $13.4 million, up $10.8 million from June 30, 2013 Cash position of $5 million with $64,000 in debt Conference Call Begins at 4:30 p.m. (EDT) Today PETALUMA, Calif., Aug.
Sign-up for Oculus Innovative Sciences Reports Revenues of $3.4 Million and Net Loss of $70,000 for First Quarter of Fiscal 2015 investment picks
Record Revenue of $98.1 Million in Q2 2014 and Sequential Revenue Growth of 14% Versus Q1 2014 Adjusted EBITDA* Reaches $6.5 Million; Strong Sequential Growth from Q1 2014 Launched WISE™, Global Eagle's Wireless Inflight Entertainment Solution, on Philippine Airlines Partnered with Boeing in Effort to Provide Line-fit Offerability on Boeing 737 and 787 Finalized Acquisition of All Remaining Outstanding Shares of AIA; Expect Significant Integration Synergies Beginning in 2H 2014 Strong Balance Sheet With $215 Million in Cash and Less Than $4 Million in Debt at Quarter End LOS ANGELES, Aug.
Sign-up for Global Eagle Entertainment Reports Second Quarter 2014 Results investment picks
BOSTON, Aug.
Sign-up for EnerNOC Reports Results for Second Quarter of 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G019670-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/7/11G019670/Vivus-751277076657.jpg MOUNTAIN VIEW, CA--(Marketwired - August 07, 2014) - VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia ® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the second quarter ended June 30, 2014 and provided a business update.
Sign-up for VIVUS Reports Second Quarter 2014 Financial Results investment picks
By Tomi Kilgore, MarketWatch UnitedHealth shares slumped after they were dropped from Goldman Sachs' conviction list amid concerns their strong run of outperformance may be nearing an end.
Sign-up for UnitedHealth drops after Goldman loses conviction investment picks
LA JOLLA, Calif.
Sign-up for Regulus to Present at the Wedbush Life Sciences Management Access Conference investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Signature Group Holdings, Inc. Reports Second Quarter 2014 Results to Regulus to Present at the Wedbush Life Sciences Management Access Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices